BDTX
Price
$2.67
Change
-$0.78 (-22.61%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
214.8M
105 days until earnings call
Intraday BUY SELL Signals
CLDX
Price
$27.82
Change
+$1.15 (+4.31%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
1.72B
89 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDTX vs CLDX

Header iconBDTX vs CLDX Comparison
Open Charts BDTX vs CLDXBanner chart's image
Black Diamond Therapeutics
Price$2.67
Change-$0.78 (-22.61%)
Volume$28.89K
Capitalization214.8M
Celldex Therapeutics
Price$27.82
Change+$1.15 (+4.31%)
Volume$10.64K
Capitalization1.72B
BDTX vs CLDX Comparison Chart in %
View a ticker or compare two or three
VS
BDTX vs. CLDX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a StrongBuy and CLDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (BDTX: $3.45 vs. CLDX: $26.66)
Brand notoriety: BDTX and CLDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 95% vs. CLDX: 37%
Market capitalization -- BDTX: $214.8M vs. CLDX: $1.72B
BDTX [@Biotechnology] is valued at $214.8M. CLDX’s [@Biotechnology] market capitalization is $1.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 0 FA rating(s) are green whileCLDX’s FA Score has 0 green FA rating(s).

  • BDTX’s FA Score: 0 green, 5 red.
  • CLDX’s FA Score: 0 green, 5 red.
According to our system of comparison, BDTX is a better buy in the long-term than CLDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 2 TA indicator(s) are bullish while CLDX’s TA Score has 7 bullish TA indicator(s).

  • BDTX’s TA Score: 2 bullish, 7 bearish.
  • CLDX’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, CLDX is a better buy in the short-term than BDTX.

Price Growth

BDTX (@Biotechnology) experienced а -10.85% price change this week, while CLDX (@Biotechnology) price change was +0.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

BDTX is expected to report earnings on Mar 18, 2026.

CLDX is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLDX($1.72B) has a higher market cap than BDTX($215M). BDTX YTD gains are higher at: 61.215 vs. CLDX (5.501). BDTX has higher annual earnings (EBITDA): 5.05M vs. CLDX (-231.4M). CLDX has more cash in the bank: 630M vs. BDTX (143M). CLDX has less debt than BDTX: CLDX (3.03M) vs BDTX (20.8M). BDTX has higher revenues than CLDX: BDTX (70M) vs CLDX (5.79M).
BDTXCLDXBDTX / CLDX
Capitalization215M1.72B12%
EBITDA5.05M-231.4M-2%
Gain YTD61.2155.5011,113%
P/E Ratio10.19N/A-
Revenue70M5.79M1,209%
Total Cash143M630M23%
Total Debt20.8M3.03M686%
FUNDAMENTALS RATINGS
BDTX vs CLDX: Fundamental Ratings
BDTX
CLDX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
69
Overvalued
PROFIT vs RISK RATING
1..100
10079
SMR RATING
1..100
6296
PRICE GROWTH RATING
1..100
3944
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
n/a38

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDTX's Valuation (56) in the null industry is in the same range as CLDX (69) in the Biotechnology industry. This means that BDTX’s stock grew similarly to CLDX’s over the last 12 months.

CLDX's Profit vs Risk Rating (79) in the Biotechnology industry is in the same range as BDTX (100) in the null industry. This means that CLDX’s stock grew similarly to BDTX’s over the last 12 months.

BDTX's SMR Rating (62) in the null industry is somewhat better than the same rating for CLDX (96) in the Biotechnology industry. This means that BDTX’s stock grew somewhat faster than CLDX’s over the last 12 months.

BDTX's Price Growth Rating (39) in the null industry is in the same range as CLDX (44) in the Biotechnology industry. This means that BDTX’s stock grew similarly to CLDX’s over the last 12 months.

BDTX's P/E Growth Rating (98) in the null industry is in the same range as CLDX (100) in the Biotechnology industry. This means that BDTX’s stock grew similarly to CLDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDTXCLDX
RSI
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 6 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
73%
Bearish Trend 6 days ago
81%
Momentum
ODDS (%)
Bearish Trend 6 days ago
82%
Bullish Trend 6 days ago
82%
MACD
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 6 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 6 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 13 days ago
89%
Bearish Trend 15 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
89%
Bullish Trend 6 days ago
75%
Aroon
ODDS (%)
N/A
Bearish Trend 6 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
BDTX
Daily Signal:
Gain/Loss:
CLDX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLOIF28.79N/A
N/A
Soitec, Bernin
BCTF13.20N/A
N/A
Bancorp 34, Inc.
CGHOF1.00N/A
N/A
China Gas Holdings Ltd.
DASTF25.85N/A
N/A
Dassault Systemes SA
MDXXF0.07N/A
N/A
PharmAla Biotech Holdings Inc.

BDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with RLAY. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
-8.49%
RLAY - BDTX
50%
Loosely correlated
+1.22%
CRBU - BDTX
48%
Loosely correlated
-0.56%
VYGR - BDTX
47%
Loosely correlated
-4.89%
KURA - BDTX
45%
Loosely correlated
-2.53%
CLDX - BDTX
44%
Loosely correlated
+2.85%
More

CLDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDX has been loosely correlated with BEAM. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDX
1D Price
Change %
CLDX100%
+2.85%
BEAM - CLDX
55%
Loosely correlated
-2.83%
XNCR - CLDX
54%
Loosely correlated
-3.15%
KURA - CLDX
53%
Loosely correlated
-2.53%
CRNX - CLDX
53%
Loosely correlated
-0.53%
VRDN - CLDX
52%
Loosely correlated
-3.26%
More